SPONSOR: Riley
This bill modifies the rule for determining the admissibility of evidence of collateral source payments in civil actions. The bill prohibits any party from introducing evidence of the amount billed for medical treatment if the amount has been discounted, written - off, or satisfied by payment of an amount less than the amount billed. The actual cost of medical care or treatment rendered and discounts shall be admissible evidence relevant to the potential cost of future treatment.
This bill is similar to HB 273 (2023) and HB 1715 (2022).
Statutes affected: